ORBIMED ADVISORS LLC

13F Portfolio Filings

Most recent 13F
Q4 2023
Location
New York, NY
CIK
0001055951
All SEC filings
View on sec.gov
Holdings Value
Quarter Holdings Value ($000) Top Holdings Form Type Date Filed Filing ID
Q4 2023 111 5,007,244 SINX, BIIB, LLY, BSX 13F-HR 2/14/2024 000117266124001461
Q3 2023 128 4,707,565 SINX, BSX, HUM, ISRG 13F-HR 11/14/2023 000117266123004019
Q2 2023 127 5,518,910 SINX, ISRG, ELVN, BSX 13F-HR 8/14/2023 000117266123003177
Q1 2023 125 5,094,046 SINX, ELVN, BSX, HUM 13F-HR 5/15/2023 000117266123002323
Q4 2022 116 5,227,458 SINX, UNH, BMY, BSX 13F-HR 2/14/2023 000117266123001310
Q3 2022 132 5,387,000 SINX, BMY, HUM, SWTX 13F-HR 11/14/2022 000117266122002553
Q2 2022 145 5,518,815 SINX, BMY, HUM, HZNP 13F-HR 8/15/2022 000117266122001998
Q1 2022 145 6,167,262 SWTX, HZNP, BSX, PFE 13F-HR 5/16/2022 000117266122001456
Q4 2021 159 7,778,455 SWTX, BMY, HZNP, BSX 13F-HR 2/14/2022 000117266122000795
Q3 2021 173 9,099,330 SWTX, PRLD, HZNP, MRK 13F-HR 11/15/2021 000117266121002332
Q2 2021 160 9,886,767 SWTX, BMY, EWTX, BSX 13F-HR 8/16/2021 000117266121001841
Q1 2021 159 10,694,926 SWTX, EWTX, PRLD, SPRY 13F-HR 5/17/2021 000117266121001345
Q4 2020 149 11,428,040 PRLD, SWTX, PMVP, SPRY 13F-HR 2/16/2021 000117266121000786
Q3 2020 143 7,956,183 PRLD, SWTX, PMVP, ALXN 13F-HR 11/16/2020 000117266120002295
Q2 2020 135 7,102,993 SWTX, TCDA, ALXN, ASND 13F-HR 8/14/2020 000117266120001859
Q1 2020 142 5,950,362 ASND, TCDA, ALEC, SWTX 13F-HR 5/15/2020 000117266120001407
Q4 2019 136 7,004,336 ASND, THOR, TCDA, SWTX 13F-HR 2/14/2020 000117266120000859
Q3 2019 116 5,269,963 ASND, TCDA, BSX, ALEC 13F-HR 11/14/2019 000117266119002352
Q2 2019 128 6,457,032 ASND, TCDA, BSX, ALXN 13F-HR 8/14/2019 000117266119001883
Q1 2019 124 6,459,711 ASND, TCDA, CMTA, ALXN 13F-HR 5/15/2019 000117266119001382
Q4 2018 131 5,407,812 TCDA, ASND, BIIB, CELG 13F-HR 2/14/2019 000117266119000868
Q3 2018 150 8,302,401 ALXN, TCDA, BIIB, VRTX 13F-HR 11/14/2018 000117266118002168
Q2 2018 147 8,384,406 ALXN, BIIB, TCDA, BSX 13F-HR 8/14/2018 000117266118001660
Q1 2018 141 8,065,259 ALXN, REGN, VRTX, MRK 13F-HR 5/15/2018 000117266118001239
Q4 2017 133 7,905,721 BIIB, ALXN, REGN, CELG 13F-HR 2/14/2018 000117266118000795
Q3 2017 143 10,463,804 ALXN, BIIB, CELG, BSX 13F-HR 11/14/2017 000117266117002146
Q2 2017 138 9,540,384 ALXN, CELG, BIIB, BSX 13F-HR 8/14/2017 000117266117001699
Q1 2017 136 8,822,204 ALXN, BIIB, CELG, BSX 13F-HR 5/15/2017 000117266117001216
Q4 2016 132 7,848,022 ALXN, BIIB, CELG, BSX 13F-HR 2/14/2017 000117266117000766
Q3 2016 140 8,780,843 BIIB, BSX, AMGN, ALXN 13F-HR 11/14/2016 000117266116004318
Q2 2016 137 9,583,046 BSX, AMGN, ABBV, BMY 13F-HR 8/15/2016 000117266116003893
Q1 2016 141 9,503,629 BMY, HCA, AMGN, BSX 13F-HR 5/16/2016 000117266116003439
Q4 2015 130 11,043,258 BMY, AMGN, BSX, AGN 13F-HR 2/16/2016 000117266116002937
Q3 2015 132 9,905,986 BMY, HCA, AMGN, BSX RESTATEMENT 11/18/2015 000117266115002104
Q2 2015 1 1,664,037 Bacterin International Holdings Inc NEW HOLDINGS 8/20/2015 000117266115001668
Q2 2015 136 11,964,202 BIIB, BMY, AGN, HCA 13F-HR 8/14/2015 000117266115001654
Q1 2015 135 11,714,377 ACTAVIS PLC, BMY, BIIB, AMGN 13F-HR 5/15/2015 000117266115001221
Q4 2014 131 10,464,861 BIIB, BMY, AMGN, CELG 13F-HR 2/13/2015 000117266115000419
Q3 2014 130 9,573,927 GILD, BIIB, BMY, AMGN 13F-HR 11/14/2014 000117266114001849
Q2 2014 132 8,516,434 ICPT, BMY, BIIB, ABBV 13F-HR 8/14/2014 000117266114001491
Q1 2014 140 8,131,588 ICPT, GILD, BIIB, BMY 13F-HR 5/15/2014 000117266114001118
Q4 2013 120 6,804,448 GILD, BIIB, CELG, BMY 13F-HR 2/14/2014 000117266114000746
Additional filings from Orbimed Advisors LLC that have since been restated